AS
JAZZ icon

Altshuler Shaham’s Jazz Pharmaceuticals JAZZ Stock Holding History

Altshuler Shaham’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-175
Closed -$23K – 533
2022
Q3 		$23K Buy
+175
New +$26.6K ﹤0.01% 386
2021
Q2 		– Sell
-238
Closed -$39K – 671
2021
Q1 		$39K Sell
238
-7
-3% -$1.15K ﹤0.01% 327
2020
Q4 		$40K Buy
+245
New +$36.5K ﹤0.01% 294
2020
Q2 		– Sell
-7
Closed -$1K – 457
2020
Q1 		$1K Hold
7
– – ﹤0.01% 407
2019
Q4 		$1K Buy
+7
New +$953 ﹤0.01% 451

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Altshuler Shaham's JAZZ Position: Q4 2022 in Review

Altshuler Shaham sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2022, closing a stake of 175 shares — an estimated $23K sold.

Altshuler Shaham first reported a position in JAZZ in Q4 2019 and held it in 5 quarters. The position peaked at $40K in Q4 2020. 485 funds tracked by Wall St. Rank hold JAZZ as of Q4 2022.

  • Altshuler Shaham reported no remaining Jazz Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Altshuler Shaham sold 175 Jazz Pharmaceuticals shares in Q4 2022, an estimated $23K.
  • Altshuler Shaham first reported a position in Jazz Pharmaceuticals in Q4 2019 and held it in 5 quarters.
  • Altshuler Shaham's Jazz Pharmaceuticals position peaked at $40K in Q4 2020.
  • 485 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2022.

Based on Altshuler Shaham's 13F filing for Q4 2022, filed 15 Feb 2023.